Previous Article | Next Article 
Journal of Clinical Microbiology, January 1998, p. 100-104, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Abiotrophia elegans sp. nov., a Possible
Pathogen in Patients with Culture-Negative Endocarditis
Andreas
Roggenkamp,1,*
Marianne
Abele-Horn,1
Karl-Heinz
Trebesius,1
Ursula
Tretter,2
Ingo B.
Autenrieth,1 and
Jürgen
Heesemann1
Max von Pettenkofer-Institute for Hygiene and
Medical Microbiology, Ludwig Maximilians University Munich, 80336 Munich,1 and
Krankenhaus Dritter Orden,
1 Medical Ward, 80638 Munich,2 Germany
Received 14 August 1997/Returned for modification 16 September
1997/Accepted 10 October 1997
 |
ABSTRACT |
We isolated a hitherto undescribed microorganism from a patient
with endocarditis. The microscopic appearance, a negative catalase
reaction, and growth as satellite colonies next to Staphylococcus epidermidis suggested that this microorganism is a member of the genus Abiotrophia, formerly known as nutritionally variant
streptococci. However, the clinical isolate described herein differed
markedly from the known Abiotrophia spp., A. adiacens and A. defectiva, in terms of its (i)
biochemical properties, (ii) restricted growth temperature range, (iii)
whole-cell lysate polypeptide profile, and (iv) unique nutritional
requirements. In contrast to the type strains of A. adiacens and A. defectiva, which used
L-cysteine and pyridoxal hydrochloride as growth factors,
the growth of the clinical isolate was only supported by
L-cysteine hydrochloride and not by pyridoxal hydrochloride
when the organism was tested in Todd-Hewitt or casein-soy peptone
broth. Comparative 16S rRNA gene sequence analysis revealed that the
microorganism was a member of the genus Abiotrophia and was
most closely related to A. adiacens (96.9% homology).
Phenotypic and phylogenetic data are consistent with the assumption of
a new species within the genus Abiotrophia, for which we
propose the name Abiotrophia elegans sp. nov. The unique
nutritional requirements of this strain are of importance for
diagnostic laboratories. The media of blood culture systems supplemented only with pyridoxal hydrochloride as a growth factor may
fail to promote the growth of A. elegans sp. nov., and
thus, these systems might not detect this microorganism as a possible cause of endocarditis.
 |
INTRODUCTION |
Nutritionally variant streptococci
(NVS) were originally isolated by Frenkel and Hirsch (9)
from patients with endocarditis and otitis media and were described as
ungroupable viridans group streptococci that grow as satellite colonies
around other bacteria. These organisms have been shown to grow in
complex media supplemented with L-cysteine or pyridoxal
hydrochloride (vitamin B6) (6, 9). NVS are
members of the normal flora of the human pharynx and the human
urogenital and intestinal tracts (13, 14). NVS are the
causes of 5% of cases of streptococcal endocarditis, including most of
the so-called blood culture-negative cases of endocarditis. Moreover,
NVS have been isolated from patients with a variety of other infectious
diseases (3, 13).
The taxonomic position of NVS remained unclear until Bouvet et al.
(3) performed DNA-DNA hybridization studies and named the
NVS Streptococcus adjacens and Streptococcus
defectivus. In 1995 Kawamura et al. (11) determined the
16S rRNA sequences of the type strains of Streptococcus
adjacens and Streptococcus defectivus and placed them
in the new genus Abiotrophia as Abiotrophia adiacens and Abiotrophia defectiva, respectively,
because of their levels of low sequence homology to other
Streptococcus species.
 |
CASE REPORT |
A 38-year-old patient was admitted to the Hospital Dritter Orden
in Munich, Germany, presenting with clinical signs of acute endocarditis (aortic valve). Four consecutive blood cultures revealed growth of a gram-positive bacterium. The patient was treated
empirically with piperacillin-tacobactam and gentamicin. Despite the
antimicrobial therapy, the patient's fever persisted and two
more blood cultures were positive for the gram-positive bacterium.
Therefore, vancomycin was added to the treatment protocol.
However, the endocarditis had a rapid course, signs of valvular
insufficiency appeared, and an early surgical intervention was
necessary. The aortic valve was replaced, and the antimicrobial therapy
was continued for a further 10 days. The patient was released from the
hospital without fever after 14 days. The blood culture isolate was
then characterized in more detail.
 |
MATERIALS AND METHODS |
Bacterial strains.
A. defectiva SC10 (ATCC 49176),
A. adiacens GaD (ATCC 49175), and A. elegans
B1333 (clinical isolate) were grown an Schaedler agar base (Difco
Laboratories GmbH, Augsburg, Germany) supplemented with 7%
defibrinated sheep blood (Oxoid, Unipath Ltd., Basingstoke, England) at
37°C.
Biochemical differentiation.
Tests for tolerance to bile
esculin and 6.5% NaCl were performed by the method of Facklam
(8). Biochemical testing was performed with the API 20 Strep
identification system (bio-Merieux Ltd., Marcy l'Etoile, France) as
described by Bouvet et al. (5), with modifications, and
values were obtained after 4 h and 1 and 7 days of incubation at
37°C.
Growth characteristics and nutritional requirements.
Microorganisms grown on Schaedler blood agar at 37°C for 24 h
were resuspended in Todd-Hewitt broth (THB; Difco) to an optical density at 600 nm (OD600) of 1.0. The bacterial suspensions
were diluted 1:100 in THB (resulting in an OD600 of <0.01)
with or without the following growth factors: pyridoxal hydrochloride (final concentration, 0.001%) and L-cysteine
hydrochloride, D-alanine, and L-alanine (final
concentrations, 0.01%; Sigma-Aldrich Chemie GmbH, Deisenhofen,
Germany). After incubation at 37°C for 24 h the
OD600s of the liquid cultures were determined.
OD600 values of <0.04 were defined as negative (no
growth), and OD600 values of >0.15 were considered
positive (multiplication). Possible microbial contaminations of
positive cultures were excluded by plating 10 µl of the culture broth
on blood agar plates lacking growth factors. In addition, bacterial
strains were characterized by satellite tests on Trypticase soy agar
(TSA; Oxoid, Unipath Ltd.) as described by Bouvet et al.
(4), with minor modifications. Fresh bacterial cultures (30 µl of a suspension with an OD600 of 1.0) were streaked onto the surfaces of TSA plates. Then, filter discs containing 5 µl
of 5 mM L-cysteine, D-alanine,
L-alanine, and 0.1% pyridoxal hydrochloride, respectively,
were placed onto the streaked cultures. After 48 h of incubation
at 37°C, the growth of small colonies around the filter discs
indicated a requirement for the respective nutrition factor.
Growth (colony formation) on Schaedler blood agar plates incubated at
different temperatures was determined after 48 h. All tests were
repeated at least three times to check their reproducibilities.
Chromophore assay.
The presence of a pH-dependent
chromophore was tested as described by van de Rijn and Bouvet
(18), with the modification that
L-cysteine-supplemented THB was used as the growth medium.
Whole-cell lysates.
Strains grown on Schaedler blood agar
plates for 24 h at 37°C were removed with a loop, washed twice
in phosphate-buffered saline (pH 7.5), and resuspended in the same
volume of 2× Laemmli sample buffer containing 10% 2-mercaptoethanol.
The samples were boiled for 10 min and centrifuged at 10,000 × g for 30 s, and the supernatant was analyzed by sodium
dodecyl sulfate (SDS)-11% polyacrylamide gel electrophoresis (PAGE)
(12).
16S rRNA gene sequence analysis.
The amplification and
direct sequencing of the gene encoding the 16S rRNA was done as
described previously (7), but with some modifications.
Universal primers corresponding to the Escherichia coli 16S
rRNA gene from bp 8 to 28 and bp 1542 to 1522 were used for PCR
amplification. For solid-phase DNA sequencing one of the oligonucleotides was biotinylated at the 5' end. Dynabeads were used
for the preparation of single-stranded DNA as recommended by the
manufacturer (DYNAL GmbH, Hamburg, Germany). In addition to the
oligonucleotides mentioned above, forward and reverse oligonucleotides corresponding to conserved regions of the 16S rRNA gene were used for
sequencing (bp 341 to 361, 515 to 531, 785 to 804, 1101 to 1114, and
1391 to 1406). The PCR products were sequenced by the Taq
DyeDideoxy terminator method with a 377XL DNA Sequencer (Applied Biosystems GmbH, Darmstadt, Germany). All sequence analyses were performed with the sequence analysis software package GCG (Genetics Computer Group, Inc., Madison, Wis.). Sequence data for comparisons were obtained from GenBank. A matrix of pairwise evolutionary distances
between aligned sequences (similarity matrix) was constructed and was
corrected by the method of Jukes and Cantor (10). A phylogenetic tree was created by the neighbor-joining method (15, 17).
Nucleotide sequence accession number.
The nucleotide
sequence of the 16S rRNA gene of A. elegans B1333 have been
deposited in the GenBank Data Library under accession no. AF016390.
 |
RESULTS |
Isolation and microbiological characterization of strain
B1333.
Strain B1333 was isolated in a culture bottle (Oxoid)
containing blood from a patient suffering from endocarditis. Small
unpigmented colonies with
-hemolysis grew after 48 h of
anaerobic incubation at 37°C on Schaedler blood agar plates. No
bacterial growth was observed on TSA blood agar plates, and hardly any
growth was observed on chocolate agar plates after incubation for
48 h in 5% CO2. Gram staining of colonies from
Schaedler blood agar plates as well as from a dried droplet of blood
cultured in bouillon showed an extremely pleomorphic gram-positive
microorganism with small coccoid forms (about 0.5 µm in diameter)
lying next to long elongated swollen forms (4 by 1.2 µm). The
catalase and oxidase reactions of the colonies and the motility test
were negative. A positive satellite test with growth on TSA blood agar
plates next to Staphylococcus epidermidis resembled NVS, but
biochemical characterization of the organism with the API 20 Strep
identification system gave no acceptable result. The antibiotic
susceptibility tests showed that the organism was sensitive to
penicillin G and ampicillin (MICs of both drugs, <0.016 µg/ml). Agar
diffusion testing on Schaedler-blood agar plates after 24 h of
anaerobic incubation revealed that the organism was sensitive to all
-lactam antibiotics, vancomycin, erythromycin, and ciprofloxacin.
Sequencing of the 16S rRNA gene.
The 16S rRNA gene from strain
B1333 was amplified by PCR with universal primers corresponding to bp 8 to 28 and 1544 to 1542 of the E. coli 16S rRNA gene. The PCR
product was sequenced directly in both directions. Comparison of the
sequence with those of other bacteria in the GenBank database indicated
that the gram-positive microorganism B1333 was most related to A. adiacens (96.9% homology) (Table
1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Distance matrix between aligned sequences of the 16S rRNA
genes corrected by the method of Jukes and Cantora
|
|
Biochemical characterization and whole-cell lysate profile.
The biochemical characterization of strain B1333 was repeated as
described by Bouvet et al. (5), with minor modifications for
the differentiation of NVS, and the biochemical properties of B1333
were compared with those of the type strains of A. adiacens (ATCC 49175) and A. defectiva (ATCC 49176). The different
biochemical properties of the strains are presented in Table
2. To confirm the distinction between
strain B1333 and the two type strains of Abiotrophia, we
analyzed the whole-cell lysate polypeptide profile by SDS-PAGE (Fig.
1). Corresponding to the results of the
16S rRNA gene sequencing, strain B1333 seems to be more related to
A. adiacens than to A. defectiva but differed
significantly from A. adiacens in more than six polypeptide
bands.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 1.
Coomassie-stained SDS-polyacrylamide gels.
Microorganisms grown on Schaedler blood agar plates were washed twice
in phosphate-buffered saline, resuspended in sample buffer, boiled, and
separated by SDS-11% PAGE. The polypeptide profiles were visualized
by Coomassie staining. Lane 1, low-molecular-mass markers (94, 67, 43, 30, 20, and 14 kDa); lane 2, A. adiacens; lane 3, A. defectiva; lane 4, strain B1333.
|
|
Growth characteristics and nutritional requirements.
The
pleomorphology of Abiotrophia cells upon Gram staining is a
hallmark of Abiotrophia spp. and is influenced by the
nutritional state of the organisms. Gram staining performed in parallel
with freshly grown cultures (Schaedler blood agar) showed that the morphology of strain B1333 was much more variable than that of A. adiacens, whereas A. defectiva presented quite regular
coccoid forms. This behavior prompted us to study the nutritional
requirements of strain B1333 in comparison to those of the type strains
of Abiotrophia. For standardization we determined the growth
by measuring the OD600 in supplemented THB and compared the
results with those of satellite tests performed on TSA, which recorded
colony formation next to a nutritional factor. The results are
presented in Table 3. Both test systems
gave nearly identical results and demonstrated the known nutritional
requirements for A. adiacens and A. defectiva. To
our surprise, strain B1333 did not use vitamin B6 as a
growth factor, but the type strains of Abiotrophia did.
However, growth could be stimulated with L-cysteine
hydrochloride. As suggested previously (1), vitamin
B6 is used during cell wall biosynthesis by conversion of
L-alanine to D-alanine. Therefore, we also
tested whether these amino acids are growth factors.
D-Alanine promoted the growth of A. adiacens but
not that of A. defectiva or strain B1333. The effect of
D-alanine was weak and was detectable only in supplemented
THB, possibly because of the sensitivity of this test system.
We tested whether B1333 also grows in the BACTEC blood culture system
(Becton Dickinson, Cockeysville, Md.) containing pyridoxal
hydrochloride (vitamin B
6) as the growth factor. Aerobic
and anaerobic
BACTEC-Plus blood culture bottles were inoculated with
strain
B1333,
A. adiacens, and
A. defectiva,
respectively (100 µl; OD
600,
1.0). While the BACTEC blood
culture system detected the growth
of
A. adiacens and
A. defectiva after 1 or 2 days, strain B1333
was not
detected in this system (period of incubation, 7 days).
Gram staining
of a sample taken from the blood culture inoculated
with strain B1333
revealed no visible bacteria. However, at day
7 strain B1333 from the
bottles could be reisolated on Schaedler
blood agar plates, suggesting
that B1333 did not multiply in BACTEC
blood culture medium but
persisted in this medium for at least
7 days. In contrast, strain B1333
grew well in Oxoid blood culture
bottles, which are supplemented with
L-cysteine.
 |
DISCUSSION |
The growth behavior, microscopic appearance, and negative catalase
reaction of unidentified clinical isolate B1333 resembled those of
bacteria of the genus Abiotrophia, formerly known as NVS.
Sequencing of the 16S rRNA gene revealed that this pathogen is most
closely related to A. adiacens.
The genus Abiotrophia represents a phylogenetically distinct
cluster and was only remotely related to the Aerococcus and
Carnobacterium clusters (11). The relationship
between Abiotrophia and other phylogenetic groups
containing medically relevant bacteria was weak (16S rRNA homology to
Streptococcus, 85%) (Fig. 2).
Hitherto, the 16S rRNA sequences of two species of the genus
Abiotrophia have been determined. The low degree of homology
between these two species (93%) might be a hint that the genus
comprises more than these two species. The phylogenetic distance
between strain B1333 and A. adiacens is greater than 3%,
which is indicative of a separate species (16). Consistent
with this assumption, the biochemical properties of strain B1333
differed from those known for Abiotrophia spp. and had a
restricted growth temperature range compared with those of
Abiotrophia spp., a characteristic whole-cell lysate
polypeptide profile, and unusual nutritional requirements compared with
those of Abiotrophia spp. In biochemical tests members of
the genus Abiotrophia often showed different enzyme profiles
(2, 5). In the most comprehensive study Bouvet et al.
(5) characterized 60 strains of NVS and divided them into
three biotypes. Strain B1333 fits none of them. A characteristic enzymatic reaction might be the hippurate hydrolysis of B1333 which was
reported by Bouvet et al. (5) for 2 of the 60 strains.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Unrooted tree showing the phylogenetic relationships of
strain B1333 to Abiotrophia spp. and related taxa. Distances
were calculated by the neighbor-joining method. The evolutionary
distance between any two taxa is the sum of the lengths of the
horizontal lines between them. The bar indicates substitution rate per
nucleotide.
|
|
It is generally accepted that pyridoxal hydrochloride at a
concentration of 0.001% will support the growth of
Abiotrophia spp. (14). This was not the case for
strain B1333, which did not grow in pyridoxal
hydrochloride-supplemented THB or complex casein-soy peptone medium,
but the type strains of Abiotrophia did. This deficiency has
consequences for the cultivation of B1333-like strains in commercially
available blood culture systems. As a possible causative agent of
endocarditis, it will rarely be isolated in laboratories which use a
pyridoxal hydrochloride-supplemented blood culture system. Therefore,
it might be a cause of culture-negative endocarditis.
L-Cysteine works quite well as a growth factor for B1333,
but the exact enzymatic defect that is responsible for the nutritional requirement must be elucidated. Beighton et al. (2) also
suggested that NVS may have different nutritional requirements.
Although it is speculative, we assume that the genus
Abiotrophia contains more than the three species discussed
herein, and these additional species may possibly have other, yet
unknown growth requirements. In general, it is problematic to describe
a new species on the basis of the characterization of a single strain.
The successful isolation and identification of fastidious pathogens,
however, will be possible only if clinical microbiologists are aware of the unique growth requirements of the organisms.
Description of Abiotrophia elegans sp. nov.
Abiotrophia elegans (e'le.gans. L. adj.
elegans, fastidious, referring to the fastidious growth
requirements) is a gram-positive microorganism. The shape is dependent
on the nutritional state. In sufficiently supplemented nutritional
broth the bacterium appears coccoid in short chains. Lack of
appropriate growth factors results in pleomorphism and the appearance
of elongated, swollen forms. The microorganism is nonmotile,
nonsporulating, and catalase and oxidase negative and grows as a
facultative anaerobe with complex growth requirements. It grows as
satellite colonies adjacent to S. epidermidis on
trypticase-soy-sheep blood agar plates with
-hemolysis. Tiny
colonies up to 0.2 mm in diameter are formed on Schaedler-sheep blood
agar plates after 48 h, but only minimal growth is visible on
chocolate agar plates. Growth occurs at 27 and 37°C but not at 20 or
42°C. It grows in THB or casein-soy peptone bouillon supplemented
with 0.01% L-cysteine hydrochloride. It does not grow in
THB or casein-soy peptone bouillon supplemented with 0.001% pyridoxal
hydrochloride. It produces a red chromophore visualized by boiling the
microorganism at pH 2 for 5 min. It produces pyrrolidonyl-arylamidase
and leucine aminopeptidase but not alkaline phosphatase,
- or
-galactosidase,
-glucuronidase, or
-glucosidase. It hydrolyzes
hippurate. It ferments raffinose but not trehalose, inulin, lactose,
starch, or glycogen.
Strain B1333 has been deposited in the German Collection of
Microorganisms and Cell Cultures, Braunschweig, Germany, as strain
DSM
11693.
 |
ACKNOWLEDGMENT |
We are thankful to Helmut Walter for accurate sequencing of the
16S rRNA gene.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Max von
Pettenkofer-Institute for Hygiene and Medical Microbiology, Ludwig
Maximilians University Munich, Pettenkoferstr. 9a, 80336 Munich,
Germany. Phone: 49-89-51605200. Fax: 49-89-5380584. E-mail:
Rogge{at}m3401.mpk.med.uni-muenchen.de.
 |
REFERENCES |
| 1.
|
Anonymous.
1977.
Culture-negative endocarditis.
Lancet
ii:1164-1165. (Editorial.)
|
| 2.
|
Beighton, D.,
K. A. Homer,
A. Bouvet, and A. R. Storey.
1995.
Analysis of enzymatic activities for differentiation of two species of nutritionally variant streptococci, Streptococcus defectivus and Streptococcus adjacens.
J. Clin. Microbiol.
33:1584-1587[Abstract].
|
| 3.
|
Bouvet, A.,
F. Grimont, and P. A. Grimont.
1989.
Streptococcus defectivus sp. nov. and Streptococcus adjacens sp. nov., nutritionally variant streptococci from human clinical specimens.
Int. J. Syst. Bacteriol.
39:290-294[Abstract/Free Full Text].
|
| 4.
|
Bouvet, A.,
I. van de Rijn, and M. McCarty.
1981.
Nutritionally variant streptococci from patients with endocarditis: growth parameters in a semisynthetic medium and demonstration of a chromophore.
J. Bacteriol.
146:1075-1082[Abstract/Free Full Text].
|
| 5.
|
Bouvet, A.,
F. Villeroy,
F. Cheng,
C. Lamesch,
R. Williamson, and L. Gutmann.
1985.
Characterization of nutritionally variant streptococci by biochemical tests and penicillin-binding proteins.
J. Clin. Microbiol.
22:1030-1034[Abstract/Free Full Text].
|
| 6.
|
Carey, R. B.,
K. C. Gross, and R. B. Roberts.
1975.
Vitamin B6-dependent Streptococcus mitior (mitis) isolated from patients with systemic infections.
J. Infect. Dis.
131:722-726[Medline].
|
| 7.
|
Edwards, U.,
T. Rogall,
H. Blöcker,
M. Emde, and E. C. Böttger.
1989.
Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S rRNA.
Nucleic Acids Res.
17:7843-7852[Abstract/Free Full Text].
|
| 8.
|
Facklam, R. R.
1977.
Physiological differentiation of viridans streptococci.
J. Clin. Microbiol.
5:184-201[Abstract/Free Full Text].
|
| 9.
|
Frenkel, A., and W. Hirsch.
1961.
Spontaneous development of L forms of streptococci requiring secretions of other bacteria or sulphydryl compounds for normal growth.
Nature
191:728-730.
|
| 10.
|
Jukes, T. H., and C. R. Cantor.
1969.
Evolution of protein molecules, p. 21-132.
In
H. N. Munro (ed.), Mammalian protein metabolism, vol. 3. Academic Press, Inc., New York, N.Y.
|
| 11.
|
Kawamura, Y.,
X. G. Hou,
F. Sultana,
S. Liu,
H. Yamamoto, and T. Ezaki.
1995.
Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb. nov., respectively.
Int. J. Syst. Bacteriol.
45:798-803[Abstract/Free Full Text].
|
| 12.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 13.
|
Roberts, R. B.,
A. G. Krieger,
N. L. Schiller, and K. C. Gross.
1979.
Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci.
Rev. Infect. Dis.
1:955-966[Medline].
|
| 14.
|
Ruoff, K. L.
1991.
Nutritionally variant streptococci.
Clin. Microbiol. Rev.
4:184-190[Abstract/Free Full Text].
|
| 15.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 16.
|
Stackebrandt, E., and B. M. Goebel.
1994.
Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology.
Int. J. Syst. Bacteriol.
44:846-849[Abstract/Free Full Text].
|
| 17.
|
Studier, J. A., and K. J. Keppler.
1988.
A note on the neighbor-joining algorithm of Saitou and Nei.
Mol. Biol. Evol.
5:729-731[Medline].
|
| 18.
|
van de Rijn, I., and A. Bouvet.
1984.
Characterization of a pH-dependent chromophore from nutritionally variant streptococci.
Infect. Immun.
43:28-31[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, January 1998, p. 100-104, Vol. 36, No. 1
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kutzer, P., Schulze, C., Engelhardt, A., Wieler, L. H., Nordhoff, M.
(2008). Helcococcus ovis, an Emerging Pathogen in Bovine Valvular Endocarditis. J. Clin. Microbiol.
46: 3291-3295
[Abstract]
[Full Text]
-
Young, K. D.
(2006). The Selective Value of Bacterial Shape. Microbiol. Mol. Biol. Rev.
70: 660-703
[Abstract]
[Full Text]
-
Ohara-Nemoto, Y., Kishi, K., Satho, M., Tajika, S., Sasaki, M., Namioka, A., Kimura, S.
(2005). Infective Endocarditis Caused by Granulicatella elegans Originating in the Oral Cavity. J. Clin. Microbiol.
43: 1405-1407
[Abstract]
[Full Text]
-
Facklam, R.
(2002). What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes. Clin. Microbiol. Rev.
15: 613-630
[Abstract]
[Full Text]
-
INCE, A., TIEMER, B., GILLE, J., BOOS, C., RUSSLIES, M.
(2002). Total knee arthroplasty infection due to Abiotrophia defectiva. J Med Microbiol
51: 899-902
[Abstract]
[Full Text]
-
Casalta, J. P., Habib, G., La Scola, B., Drancourt, M., Caus, T., Raoult, D.
(2002). Molecular Diagnosis of Granulicatella elegans on the Cardiac Valve of a Patient with Culture-Negative Endocarditis. J. Clin. Microbiol.
40: 1845-1847
[Abstract]
[Full Text]
-
Christensen, J. J., Facklam, R. R.
(2001). Granulicatella and Abiotrophia Species from Human Clinical Specimens. J. Clin. Microbiol.
39: 3520-3523
[Abstract]
[Full Text]
-
Kanamoto, T., Sato, S., Inoue, M.
(2000). Genetic Heterogeneities and Phenotypic Characteristics of Strains of the Genus Abiotrophia and Proposal of Abiotrophia para-adiacens sp. nov.. J. Clin. Microbiol.
38: 492-498
[Abstract]
[Full Text]
-
Sato, S., Kanamoto, T., Inoue, M.
(1999). Abiotrophia elegans Strains Comprise 8% of the Nutritionally Variant Streptococci Isolated from the Human Mouth. J. Clin. Microbiol.
37: 2553-2556
[Abstract]
[Full Text]
-
Namdari, H., Kintner, K., Jackson, B. A., Namdari, S., Hughes, J. L., Peairs, R. R., Savage, D. J.
(1999). Abiotrophia Species as a Cause of Endophthalmitis Following Cataract Extraction. J. Clin. Microbiol.
37: 1564-1566
[Abstract]
[Full Text]
-
Lawson, P. A., Collins, M. D., Falsen, E., Sjöden, B., Facklam, R. R.
(1999). Facklamia languida sp. nov., Isolated from Human Clinical Specimens. J. Clin. Microbiol.
37: 1161-1164
[Abstract]
[Full Text]
-
Biermann, C., Fries, G., Jehnichen, P., Bhakdi, S., Husmann, M.
(1999). Isolation of Abiotrophia adiacens from a Brain Abscess Which Developed in a Patient after Neurosurgery. J. Clin. Microbiol.
37: 769-771
[Abstract]
[Full Text]
-
Roggenkamp, A., Leitritz, L., Baus, K., Falsen, E., Heesemann, J.
(1998). PCR for Detection and Identification of Abiotrophia spp.. J. Clin. Microbiol.
36: 2844-2846
[Abstract]
[Full Text]